SCHEMBL26239229

SCHEMBL26239229

CCS(=O)(=O)Nc1ccc(OCCN(C)CCc2ccc(NS(C)(=O)=O)cc2)cc1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 11/20 0.88
CACNA1F O60840 1/20 0.88
CHRM2 P08172 1/20 0.88
ACHE P22303 1/20 0.88
AGTR1 P30556 1/20 0.88
DRD3 P35462 1/20 0.88
CACNA1D Q01668 1/20 0.88
CACNA1S Q13698 1/20 0.88
CACNA1C Q13936 1/20 0.88
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
MAPK1 P28482 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
AR P10275 2/20 0.48
HPGD P15428 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dofetilide SCHEMBL16135 0.94 KCNH2 (1.00) KCNH2CACNA1FCHRM2ACHEAGTR1
Dofetilide SCHEMBL6102734 0.94 KCNH2 (1.00) KCNH2CACNA1FCHRM2ACHEAGTR1
Dofetilide SCHEMBL8362214 0.93 KCNH2 (0.97) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL24600680 0.88 KCNH2 (0.88) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL9628293 0.88 KCNH2 (0.88) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL9628071 0.88 KCNH2 (0.88) KCNH2CACNA1FCHRM2ACHEAGTR1
Hydrochloric Acid SCHEMBL9629110 0.86 KCNH2 (0.84) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL18678464 0.86 KCNH2 (0.84) KCNH2CACNA1FCHRM2ACHEAGTR1
Hydrochloric Acid SCHEMBL9629115 0.86 KCNH2 (0.84) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL13480196 0.84 KCNH2 (0.80) KCNH2CACNA1FCHRM2ACHEAGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025846-A1 ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS ACAD PHARMACEUTICALS INC (US) 2024-01-25 US disclosed
US-11731938-B2 Ultra short acting anti-arrhythmic agents ACADEMIC PHARMACEUTICALS INC (US) 2023-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11731938-B2 Ultra short acting anti-arrhythmic agents CACNA1G, SCN5A, CACNA1F KCNH2 51/4885CACNA1F 3/4885CHRM2 1597/4885
US-20240025846-A1 ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS CACNA1G, SCN5A, CACNA1F KCNH2 51/4885CACNA1F 3/4885CHRM2 1597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.